Total Payments
$5,194
2024 Payments
$976.87
Companies
36
Transactions
350
Medicare Patients
1,913
Medicare Billing
$196,967
Payment Breakdown by Category
Food & Beverage$5,179 (99.7%)
Education$14.82 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,179 | 345 | 99.7% |
| Education | $14.82 | 1 | 0.3% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$5,194
346 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,061 | 152 | $0 (2024) |
| Janssen Biotech, Inc. | $547.05 | 30 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $463.84 | 37 | $0 (2024) |
| PFIZER INC. | $294.66 | 28 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $180.27 | 14 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $161.69 | 8 | $0 (2024) |
| Boston Scientific Corporation | $128.59 | 8 | $0 (2024) |
| Zimmer Biomet Holdings, Inc. | $125.00 | 1 | $0 (2019) |
| QOL Medical, LLC | $114.41 | 8 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $105.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $976.87 | 47 | ABBVIE INC. ($393.70) |
| 2023 | $999.55 | 75 | AbbVie Inc. ($478.07) |
| 2022 | $679.37 | 45 | ABBVIE INC. ($508.74) |
| 2021 | $994.50 | 85 | AbbVie Inc. ($462.95) |
| 2020 | $289.46 | 19 | Janssen Biotech, Inc. ($60.84) |
| 2019 | $498.33 | 29 | Zimmer Biomet Holdings, Inc. ($125.00) |
| 2018 | $411.99 | 28 | Takeda Pharmaceuticals U.S.A., Inc. ($71.73) |
| 2017 | $343.89 | 22 | Janssen Biotech, Inc. ($54.73) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.71 | General |
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $105.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $109.12 | General |
| Category: Immunology | ||||||
| 09/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 09/03/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 08/30/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Immunology | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 442 | 631 | $782,420 | $55,357 |
| 2022 | 9 | 391 | 402 | $561,965 | $42,337 |
| 2021 | 13 | 567 | 706 | $451,955 | $53,715 |
| 2020 | 10 | 513 | 671 | $373,250 | $45,557 |
Total Patients
1,913
Total Services
2,410
Medicare Billing
$196,967
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 136 | 136 | $234,600 | $17,300 | 7.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 53 | 53 | $95,453 | $10,628 | 11.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 28 | 28 | $37,576 | $4,867 | 13.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 48 | 52 | $226,876 | $4,723 | 2.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 127 | $19,304 | $4,435 | 23.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 78 | $7,800 | $3,505 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 38 | $9,424 | $3,180 | 33.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 66 | 68 | $102,068 | $3,116 | 3.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $16,116 | $2,090 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $3,300 | $1,298 | 39.3% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $29,903 | $213.98 | 0.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 116 | 116 | $178,050 | $15,142 | 8.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 39 | 39 | $64,625 | $7,287 | 11.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 28 | 28 | $35,182 | $4,853 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 50 | $11,140 | $4,290 | 38.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 68 | 68 | $90,044 | $3,822 | 4.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 34 | 35 | $129,164 | $3,458 | 2.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 30 | $4,500 | $1,740 | 38.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 18 | $19,275 | $1,528 | 7.9% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $29,985 | $218.64 | 0.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 113 | 113 | $135,600 | $14,823 | 10.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 40 | 41 | $57,400 | $7,898 | 13.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 32 | 32 | $32,000 | $5,691 | 17.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 114 | 238 | $38,080 | $5,367 | 14.1% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 51 | 53 | $53,000 | $5,335 | 10.1% |
About Dr. Brett Doxey, MD
Dr. Brett Doxey, MD is a Gastroenterology healthcare provider based in Riverton, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386775682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brett Doxey, MD has received a total of $5,194 in payments from pharmaceutical and medical device companies, with $976.87 received in 2024. These payments were reported across 350 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,179).
As a Medicare-enrolled provider, Doxey has provided services to 1,913 Medicare beneficiaries, totaling 2,410 services with total Medicare billing of $196,967. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Riverton, UT
- Active Since 03/08/2007
- Last Updated 06/09/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1386775682
Products in Payments
- SKYRIZI (Biological) $619.55
- RINVOQ (Biological) $492.05
- STELARA (Biological) $364.44
- HUMIRA (Biological) $342.12
- ENTYVIO (Biological) $216.12
- LINZESS (Drug) $209.63
- DUPIXENT (Biological) $191.21
- XELJANZ (Drug) $185.97
- XIFAXAN (Drug) $180.27
- TREMFYA (Drug) $169.36
- Nextremity ArcusTM (Device) $125.00
- CREON (Drug) $118.34
- MAVYRET (Drug) $114.83
- INFLECTRA (Biological) $108.69
- Entyvio (Biological) $105.68
- VOQUEZNA (Drug) $105.35
- ZENPEP (Drug) $89.67
- Humira (Biological) $80.16
- Sucraid (Drug) $69.66
- Mavyret (Drug) $67.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.